R. Cosentini (Milan, Italy), D. Bouros (Alexandroupolis, Greece)
Value of hypoalbuminemia as a sign of severity of community-acquired pneumonia
F. Sanz, J. Blanquer, M. L. Briones, R. Blanquer, E. Fernández, C. Aguar, F. Tatay (Valencia, Spain)
|   |
Pneumonia in the elderly – a retrospective study of the years 2002-2006
A. Kosma, E. Kosma, E. Markopoulou, E. Kalaitzidou, V. Dramba, N. Galanis (Thessaloniki, Greece)
| |
Role of Legionella pneumophila in aetiology of hospitalized adults patients with CAP in Russia
E. Shal, S. Ratchina, R. Kozlov, O. Kretchikova, N. Ivanchik, I. Ustjuzhanin, S. Yatsyshina, T. Astakhova, T. Kondratieva (Moscow, Smolensk, Russian Federation)
| |
Impact of neutrophil function on outcomes of community-acquired pneumonia (CAP) in patients with cancer
S. Aliberti, A. Amir, P. Peyrani, J. A. Myers, M. Cirino, M. Saporiti, F. Blasi, J. A. Ramirez (Milan, Italy; Louisville, KY, United States Of America)
| |
Clinical pathway as a tool of improving quality of care in patients with CAP
R. Erzen, E. Music, M. Kosnik (Golnik, Slovenia)
| |
Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens
M. Dionaldo, A. Koh, E. Ang (Manila, Philippines)
| |
Ambulatory patients with community-acquired pneumonia in the Czech Republic: a prospective study
V. Kolek, A. Hassan, V. Bartos, P. Popelkova, V. Rihak, H. Fojtu, M. Kolar (Olomouc, Plzen, Hradec Kralove, Ostrava, Zlin, Czech Republic)
| |
Audit on pneumonia management at Mid-Staffordshire General Hospital
C. G. Choo, W. Lau, A. Fairfax (Stafford, United Kingdom)
| |
Adult Malaysian patients with community-acquired pneumonia: comparing two severity scoring systems in predicting need for ventilation
L. C. Loh, S. L. Yeo, S. Rani, A. L. Lim, M. Ezran, B. K. Lim, S. Raman, S. Wan Yusuf (Kuala Lumpur, Seremban, Malaysia)
| |
Epidemiological investigation of Legionella pneumophila infection after an outbreak in a Portuguese center
F. Guedes, D. Ferreira, R. Lima, M. Vanzeller, J. Rola (Vila Nova de Gaia, Portugal)
| |
The impact of antimicrobial resistance on the cost-effectiveness of empirical treatment of community-acquired pneumonia (CAP) in France (FR), Belgium (BE) and Germany (DE)
M. Martin, L. Moore, S. Quilici, T. File, J. Garau, M. Kubin, T. Evers (Uxbridge, Middlesex, United Kingdom; Akron, OH, United States Of America; Terrassa, Barcelona, Spain; Wuppertal, Germany)
| |
General evaluation in cases with community acquired pneumonia due to C. pneumoniae
C. Naz, F. Alatas, G. Durmaz, G. Ak, H. Yildirim, M. Metintas, S. Erginel (Eskisehir, Turkey)
| |
Anaerobic bacteria in pleuropulmonary infections
S. Marinkovic, I. Marekovic, V. Slavic-Vrzic, B. Sever, M. De¿kovic, N. Chalfe, M. Jakopovic (Zagreb, Croatia)
| |
Parapneumonic empyema – analysis of two years period
J. Stojsic, T. Adzic, S. Popevic, P. Dzeletovic, L. Nagorni-Obradovic, D. Trifunovic (Belgrade, Serbia And Montenegro)
| |
Laboratorial characteristics of pleural effusions, a new diagnostic tool for pleuropulmonary paragonimus
A. Higashi, H. Kanazawa, Y. Koreeda, K. Kubota, Y. Hagihara, K. Arimura, M. Kawabata, N. Higashi (Kagoshima, Japan)
| |
Penetration of azithromycin in experimental pleural empyema model fluid
M. Saroglou, G. Ismailos, S. Tryfon, A. Papalois, I. Liapakis, D. Bouros (Thessaloniki, Athens, Alexandroupoli, Greece)
| |
Penetration of linezolide in experimental pleural empyema model fluid
M. Saroglou, S. Tryfon, A. Papalois, I. Liapakis, E. Tzatzarakis, A. Tsatsakis, D. Bouros (Thessaloniki, Athens, Herakleio, Alexandroupoli, Greece)
| |
Correlation of accompanying pleural effusion with patient characteristics and mortality in patients with community acquired pneumonia
S. Krueger, S. Pauls, R. Marre, K. Richter, N. Suttorp, T. Welte (Ulm, Berlin, Hannover, Germany)
| |
Pleural effusions in Kumasi, Ghana – clinical and laboratory characteristics
B. Afful, S. Murphy, G. Antunes (Kumasi, Ghana; Middlesbrough, United Kingdom)
| |